Akira Matsushima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Akira Matsushima has a total of 106 co-authors. Here are the top co-authors by number of shared publications:
- Kunihiro Yoshida
Shinshu University School of Medicine
6 shared publications Shu-Ichi Ikeda
Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan
6 shared publications- Katsuya Nakamura
Department of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
4 shared publications Kunihiro Yoshida
Department of Neurology, JA Nagano Koseiren Kakeyu-Misayama Rehabilitation Center Kakeyu Hospital, Ueda, Japan
4 shared publicationsAkiyo Hineno
3 shared publicationsKazuhiro Fukushima
3 shared publications
Latest Publications
- Open Access
- 15 October 2025
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 64 (20) , 3039-3043
Treatment of Anti-myelin-associated Glycoprotein Neuropathy with Tirabrutinib and a 3-year Follow-up
A 69-year-old man was admitted to our hospital because of progressive numbness in the lower legs and fingertips as well as a burning sensation in the soles of both feet. The patient was diagnosed with anti-myelin-associated glycoprotein (anti-MAG) neuropathy based on increased serum IgM levels and anti-MAG antibody titers. Atypical pulmonary mycobacteriosis was also suspected. Following treatment with tirabrutinib (a second-generation Bruton tyrosine kinase inhibitor), his symptoms improved and the anti-MAG antibody titer and IgM levels decreased. Tirabrutinib may therefore be an effective treatment option for anti-MAG neuropathy, particularly in patients at risk of infection.
- 15 October 2025
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 64 (20) , 3039-3043
Open AccessTreatment of Anti-myelin-associated Glycoprotein Neuropathy with Tirabrutinib and a 3-year Follow-up
A 69-year-old man was admitted to our hospital because of progressive numbness in the lower legs and fingertips as well as a burning sensation in the soles of both feet. The patient was diagnosed with anti-myelin-associated glycoprotein (anti-MAG) neuropathy based on increased serum IgM levels and anti-MAG antibody titers. Atypical pulmonary mycobacteriosis was also suspected. Following treatment with tirabrutinib (a second-generation Bruton tyrosine kinase inhibitor), his symptoms improved and the anti-MAG antibody titer and IgM levels decreased. Tirabrutinib may therefore be an effective treatment option for anti-MAG neuropathy, particularly in patients at risk of infection.
- 10 May 2024
- Published by Morressier GmbH
Neurofilament light chain as a biomarker for hereditary ATTR amyloidosis - Correlation between neurofilament light chain and nerve conduction study - PB27 (#138)
**Author Listing - Lead/ Submitting Author (we will be communicating with this individual): Name, Institution, City and State where the work was | POSTER
- 10 May 2024
- Published by Morressier GmbH
Neurofilament light chain as a biomarker for hereditary ATTR amyloidosis - Correlation between neurofilament light chain and nerve conduction study - PB27 (#138)
**Author Listing - Lead/ Submitting Author (we will be communicating with this individual): Name, Institution, City and State where the work was | POSTER
- 8 May 2024
- Published by Morressier GmbH
Treatment outcome of DCyBorD therapy on patients with advanced systemic AL amyloidosis PA139 (#66)
Author Listing - Lead/ Submitting Author (we will be communicating with this individual): Name, Institution, City and State where the work was do | POSTER
- 8 May 2024
- Published by Morressier GmbH
Treatment outcome of DCyBorD therapy on patients with advanced systemic AL amyloidosis PA139 (#66)
Author Listing - Lead/ Submitting Author (we will be communicating with this individual): Name, Institution, City and State where the work was do | POSTER
- Open Access
- 8 September 2021
- Published by Springer Nature in BioMedical Engineering OnLine
- Vol. 20 (1) , 1-11
Gait training with a wearable curara® robot for cerebellar ataxia: a single-arm study
Background: Ataxic gait is one of the most common and disabling symptoms in people with degenerative cerebellar ataxia. Intensive and well-coordinated inpatient rehabilitation improves ataxic gait. In addition to therapist-assisted gait training, robot-assisted gait training has been used for several neurological disorders; however, only a small number of trials have been conducted for degenerative cerebellar ataxia. We aimed to validate the rehabilitative effects of a wearable “curara®” robot developed in a single-arm study of people with degenerative cerebellar ataxia. Methods: Twenty participants with spinocerebellar ataxia or multiple system atrophy with predominant cerebellar ataxia were enrolled. The clinical trial duration was 15 days. We used a curara® type 4 wearable robot for gait training. We measured the following items at days 0, 7, and 14: Scale for the Assessment and Rating of Ataxia, 10-m walking time (10 mWT), 6-min walking distance (6 mWD), and timed up and go test. Gait parameters (i.e., stride duration and length, standard deviation of stride duration and length, cadence, ratio of the stance and swing phases, minimum and maximum knee joint angles, and minimum and maximum hip joint angles) were obtained using a RehaGait®. On days 1–6 and 8–13, the participants were instructed to conduct gait training for 30 ± 5 min with curara®. We calculated the improvement rate as the difference of values between days 14 and 0 divided by the value on day 0. Differences in the gait parameters were analyzed using a generalized linear mixed model with Bonferroni’s correction. Results: Data from 18 participants were analyzed. The mean improvement rate of the 10 mWT and 6 mWD was 19.0% and 29.0%, respectively. All gait parameters, except the standard deviation of stride duration and length, improved on day 14. Conclusions: Two-week RAGT with curara® has rehabilitative effects on gait function comparable to those of therapist-assisted training. Although the long-term effects after a month of RAGT with curara® are unclear, curara® is an effective tool for gait training of people with degenerative ataxia. Trial registration jRCT, jRCTs032180164. Registered: 27 February 2019; retrospectively registered. https://jrct.niph.go.jp/en-latest-detail/jRCTs032180164.
- 8 September 2021
- Published by Springer Nature in BioMedical Engineering OnLine
- Vol. 20 (1) , 1-11
Open AccessGait training with a wearable curara® robot for cerebellar ataxia: a single-arm study
Background: Ataxic gait is one of the most common and disabling symptoms in people with degenerative cerebellar ataxia. Intensive and well-coordinated inpatient rehabilitation improves ataxic gait. In addition to therapist-assisted gait training, robot-assisted gait training has been used for several neurological disorders; however, only a small number of trials have been conducted for degenerative cerebellar ataxia. We aimed to validate the rehabilitative effects of a wearable “curara®” robot developed in a single-arm study of people with degenerative cerebellar ataxia. Methods: Twenty participants with spinocerebellar ataxia or multiple system atrophy with predominant cerebellar ataxia were enrolled. The clinical trial duration was 15 days. We used a curara® type 4 wearable robot for gait training. We measured the following items at days 0, 7, and 14: Scale for the Assessment and Rating of Ataxia, 10-m walking time (10 mWT), 6-min walking distance (6 mWD), and timed up and go test. Gait parameters (i.e., stride duration and length, standard deviation of stride duration and length, cadence, ratio of the stance and swing phases, minimum and maximum knee joint angles, and minimum and maximum hip joint angles) were obtained using a RehaGait®. On days 1–6 and 8–13, the participants were instructed to conduct gait training for 30 ± 5 min with curara®. We calculated the improvement rate as the difference of values between days 14 and 0 divided by the value on day 0. Differences in the gait parameters were analyzed using a generalized linear mixed model with Bonferroni’s correction. Results: Data from 18 participants were analyzed. The mean improvement rate of the 10 mWT and 6 mWD was 19.0% and 29.0%, respectively. All gait parameters, except the standard deviation of stride duration and length, improved on day 14. Conclusions: Two-week RAGT with curara® has rehabilitative effects on gait function comparable to those of therapist-assisted training. Although the long-term effects after a month of RAGT with curara® are unclear, curara® is an effective tool for gait training of people with degenerative ataxia. Trial registration jRCT, jRCTs032180164. Registered: 27 February 2019; retrospectively registered. https://jrct.niph.go.jp/en-latest-detail/jRCTs032180164.
- Open Access
- 19 March 2021
- Published by Springer Nature in Research Square
Gait training with a wearable curara® robot for cerebellar ataxia: a single-arm study
Background: Ataxic gait is one of the most common and problematic symptoms in people with degenerative cerebellar ataxia. Intensive and well-coordinated inpatient rehabilitation has been shown to improve ataxic gait. In addition to therapist-assisted gait training, robot-assisted gait training has been introduced for several neurological disorders; however, only a small number of trials have been conducted for degenerative cerebellar ataxia. We aimed to validate the rehabilitation effect of a wearable “curara®” robot we developed in a single-arm study of people with degenerative cerebellar ataxia.Methods: Twenty participants with spinocerebellar ataxia or multiple system atrophy with predominant cerebellar ataxia were enrolled. The clinical trial period was 15 days. We used a curara® type 4 wearable robot for gait training. We measured the following items on days 0, 7, and 14: Scale for the Assessment and Rating of Ataxia, 10-m walking time (10mWT), 6-min walking distance (6MWD), and timed up and go test. Gait parameters (i.e., stride duration and length, standard deviation of stride duration and length, cadence, ratio of the stance/swing phases, minimum/maximum knee joint angle, and minimum/maximum hip joint angle) were obtained using a RehaGait®. On the other days (days 1–6 and 8–13), the participants were instructed to conduct gait training for 30 ± 5 min with curara®. We calculated the improvement rate as the difference of values between days 14 and 0 divided by the value on day 0. Differences in the gait parameters were analyzed using a generalized linear mixed model with Bonferroni’s correction.Results: Eighteen participants were analyzed. The mean improvement rate of the 10mWT and 6MWD was 19.0% and 29.0%, respectively. All gait parameters, except the standard deviation of stride duration and length, improved on day 14.Conclusions: The wearable curara® robot has the potential to facilitate gait training in people with degenerative cerebellar ataxia.Trial registration: jRCT, jRCTs032180164. Registered 27 February 2019 - Retrospectively registered, https://jrct.niph.go.jp/en-latest-detail/jRCTs032180164
- 19 March 2021
- Published by Springer Nature in Research Square
Open AccessGait training with a wearable curara® robot for cerebellar ataxia: a single-arm study
Background: Ataxic gait is one of the most common and problematic symptoms in people with degenerative cerebellar ataxia. Intensive and well-coordinated inpatient rehabilitation has been shown to improve ataxic gait. In addition to therapist-assisted gait training, robot-assisted gait training has been introduced for several neurological disorders; however, only a small number of trials have been conducted for degenerative cerebellar ataxia. We aimed to validate the rehabilitation effect of a wearable “curara®” robot we developed in a single-arm study of people with degenerative cerebellar ataxia.Methods: Twenty participants with spinocerebellar ataxia or multiple system atrophy with predominant cerebellar ataxia were enrolled. The clinical trial period was 15 days. We used a curara® type 4 wearable robot for gait training. We measured the following items on days 0, 7, and 14: Scale for the Assessment and Rating of Ataxia, 10-m walking time (10mWT), 6-min walking distance (6MWD), and timed up and go test. Gait parameters (i.e., stride duration and length, standard deviation of stride duration and length, cadence, ratio of the stance/swing phases, minimum/maximum knee joint angle, and minimum/maximum hip joint angle) were obtained using a RehaGait®. On the other days (days 1–6 and 8–13), the participants were instructed to conduct gait training for 30 ± 5 min with curara®. We calculated the improvement rate as the difference of values between days 14 and 0 divided by the value on day 0. Differences in the gait parameters were analyzed using a generalized linear mixed model with Bonferroni’s correction.Results: Eighteen participants were analyzed. The mean improvement rate of the 10mWT and 6MWD was 19.0% and 29.0%, respectively. All gait parameters, except the standard deviation of stride duration and length, improved on day 14.Conclusions: The wearable curara® robot has the potential to facilitate gait training in people with degenerative cerebellar ataxia.Trial registration: jRCT, jRCTs032180164. Registered 27 February 2019 - Retrospectively registered, https://jrct.niph.go.jp/en-latest-detail/jRCTs032180164
- 1 July 2020
- Published by Elsevier in Gait & Posture
- Vol. 80, 168-173
Kinematic gait asymmetry assessment using joint angle data in patients with chronic stroke—A normalized cross-correlation approach
- 1 July 2020
- Published by Elsevier in Gait & Posture
- Vol. 80, 168-173
Kinematic gait asymmetry assessment using joint angle data in patients with chronic stroke—A normalized cross-correlation approach
- 21 March 2018
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Neural Systems and Rehabilitation Engineering
- Vol. 26 (5) , 1011-1016
Effect of the Synchronization-Based Control of a Wearable Robot Having a Non-Exoskeletal Structure on the Hemiplegic Gait of Stroke Patients
We have been developing the robotic wear curara® as both a welfare device and rehabilitation robot that assists the elderly and disabled. curara® is aimed at user friendliness. We have thus chosen a non-exoskeleton structure made of a plastic so that the robot is as light in weight as possible and to minimize the restraining stress against natural human movement. We verified the assistance effect of curara® on 15 hemiplegic patients with stroke by comparing gait parameters (i.e., velocity, step length, cadence, and symmetry of joint angles) among three conditions. The conditions were “without assistance” (i.e., a control mode that cancels frictional resistances in actuators), Condition A (where joint angles are enlarged but there is no change in gait cycle), and Condition B (where there is no change in joint angles but the gait cycle is shortened). curara® improved the walking velocity by 19% and 27% under Conditions A and B, respectively. Improvements in step length and cadence were respectively 11% and 7% under Condition A and 14% and 11% under Condition B. Moreover, the two assistance conditions reduced the difference in joint angles between unaffected and paralyzed legs. We consider that curara® will facilitate the rehabilitation of stroke patients.
- 21 March 2018
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Neural Systems and Rehabilitation Engineering
- Vol. 26 (5) , 1011-1016
Effect of the Synchronization-Based Control of a Wearable Robot Having a Non-Exoskeletal Structure on the Hemiplegic Gait of Stroke Patients
We have been developing the robotic wear curara® as both a welfare device and rehabilitation robot that assists the elderly and disabled. curara® is aimed at user friendliness. We have thus chosen a non-exoskeleton structure made of a plastic so that the robot is as light in weight as possible and to minimize the restraining stress against natural human movement. We verified the assistance effect of curara® on 15 hemiplegic patients with stroke by comparing gait parameters (i.e., velocity, step length, cadence, and symmetry of joint angles) among three conditions. The conditions were “without assistance” (i.e., a control mode that cancels frictional resistances in actuators), Condition A (where joint angles are enlarged but there is no change in gait cycle), and Condition B (where there is no change in joint angles but the gait cycle is shortened). curara® improved the walking velocity by 19% and 27% under Conditions A and B, respectively. Improvements in step length and cadence were respectively 11% and 7% under Condition A and 14% and 11% under Condition B. Moreover, the two assistance conditions reduced the difference in joint angles between unaffected and paralyzed legs. We consider that curara® will facilitate the rehabilitation of stroke patients.
- Open Access
- 1 January 2018
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 384, 30-35
Idiopathic cerebellar ataxia (IDCA): Diagnostic criteria and clinical analyses of 63 Japanese patients
- 1 January 2018
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 384, 30-35
Open AccessIdiopathic cerebellar ataxia (IDCA): Diagnostic criteria and clinical analyses of 63 Japanese patients